Brain endothelial cell TRPA1 channels initiate neurovascular coupling

  1. Pratish Thakore
  2. Michael G Alvarado
  3. Sher Ali
  4. Amreen Mughal
  5. Paulo W Pires
  6. Evan Yamasaki
  7. Harry A T Pritchard
  8. Brant E Isakson
  9. Cam Ha T Tran
  10. Scott Earley  Is a corresponding author
  1. University of Nevada, Reno, United States
  2. University of Vermont, United States
  3. University of Arizona, Tucson, United States
  4. University of Manchester, United Kingdom
  5. University of Virginia, United States

Abstract

Cerebral blood flow is dynamically regulated by neurovascular coupling to meet the dynamic metabolic demands of the brain. We hypothesized that TRPA1 channels in capillary endothelial cells are stimulated by neuronal activity and instigate a propagating retrograde signal that dilates upstream parenchymal arterioles to initiate functional hyperemia. We find that activation of TRPA1 in capillary beds and post-arteriole transitional segments with mural cell coverage initiates retrograde signals that dilate upstream arterioles. These signals exhibit a unique mode of biphasic propagation. Slow, short-range intercellular Ca2+ signals in the capillary network are converted to rapid electrical signals in transitional segments that propagate to and dilate upstream arterioles. We further demonstrate that TRPA1 is necessary for functional hyperemia and neurovascular coupling within the somatosensory cortex of mice in vivo. These data establish endothelial cell TRPA1 channels as neuronal activity sensors that initiate microvascular vasodilatory responses to redirect blood to regions of metabolic demand.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files. Source data files have been provided for all figures and figure supplements.

Article and author information

Author details

  1. Pratish Thakore

    Department of Pharmacology, School of Medicine, University of Nevada, Reno, Reno, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2086-5453
  2. Michael G Alvarado

    Department of Pharmacology, School of Medicine, University of Nevada, Reno, Reno, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3489-9021
  3. Sher Ali

    Department of Pharmacology, School of Medicine, University of Nevada, Reno, Reno, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Amreen Mughal

    Department of Pharmacology, College of Medicine, University of Vermont, Burlington, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0046-2286
  5. Paulo W Pires

    Department of Physiology, College of Medicine, University of Arizona, Tucson, Tucson, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5972-4554
  6. Evan Yamasaki

    Department of Pharmacology, School of Medicine, University of Nevada, Reno, Reno, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Harry A T Pritchard

    Institute of Cardiovascular Sciences, University of Manchester, Manchester, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  8. Brant E Isakson

    Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Cam Ha T Tran

    Department of Pharmacology, School of Medicine, University of Nevada, Reno, Reno, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Scott Earley

    Department of Pharmacology, School of Medicine, University of Nevada, Reno, Reno, United States
    For correspondence
    searley@med.unr.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9560-2941

Funding

National Heart, Lung, and Blood Institute (R01HL091905)

  • Scott Earley

National Institute of General Medical Sciences (P20GM130459)

  • Scott Earley

National Heart, Lung, and Blood Institute (R35HL155008)

  • Scott Earley

National Heart, Lung, and Blood Institute (R01HL137852)

  • Scott Earley

National Heart, Lung, and Blood Institute (R01HL139585)

  • Scott Earley

National Heart, Lung, and Blood Institute (R01HL146054)

  • Scott Earley

National Heart, Lung, and Blood Institute (K99HL140106)

  • Paulo W Pires

National Heart, Lung, and Blood Institute (P01HL120840)

  • Brant E Isakson

National Heart, Lung, and Blood Institute (R01HL137112)

  • Brant E Isakson

National Institute of Neurological Disorders and Stroke (RF1NS110044)

  • Scott Earley

National Institute of Neurological Disorders and Stroke (R61NS115132)

  • Scott Earley

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal procedures used in this study were approved by the Institutional Animal Care and Use Committee of the University of Nevada, Reno, School of Medicine (protocol number: 20-06-1020).

Reviewing Editor

  1. Kenton J Swartz, National Institute of Neurological Disorders and Stroke, National Institutes of Health, United States

Publication history

  1. Received: September 11, 2020
  2. Accepted: February 25, 2021
  3. Accepted Manuscript published: February 26, 2021 (version 1)
  4. Version of Record published: March 5, 2021 (version 2)

Copyright

© 2021, Thakore et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,503
    Page views
  • 364
    Downloads
  • 40
    Citations

Article citation count generated by polling the highest count across the following sources: Scopus, Crossref, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Pratish Thakore
  2. Michael G Alvarado
  3. Sher Ali
  4. Amreen Mughal
  5. Paulo W Pires
  6. Evan Yamasaki
  7. Harry A T Pritchard
  8. Brant E Isakson
  9. Cam Ha T Tran
  10. Scott Earley
(2021)
Brain endothelial cell TRPA1 channels initiate neurovascular coupling
eLife 10:e63040.
https://doi.org/10.7554/eLife.63040

Further reading

    1. Genetics and Genomics
    2. Neuroscience
    Carolyn Elya, Danylo Lavrentovich ... Benjamin de Bivort
    Research Article Updated

    For at least two centuries, scientists have been enthralled by the “zombie” behaviors induced by mind-controlling parasites. Despite this interest, the mechanistic bases of these uncanny processes have remained mostly a mystery. Here, we leverage the Entomophthora muscae-Drosophila melanogaster “zombie fly” system to reveal the mechanistic underpinnings of summit disease, a manipulated behavior evoked by many fungal parasites. Using a high-throughput approach to measure summiting, we discovered that summiting behavior is characterized by a burst of locomotion and requires the host circadian and neurosecretory systems, specifically DN1p circadian neurons, pars intercerebralis to corpora allata projecting (PI-CA) neurons and corpora allata (CA), the latter being solely responsible for juvenile hormone (JH) synthesis and release. Using a machine learning classifier to identify summiting animals in real time, we observed that PI-CA neurons and CA appeared intact in summiting animals, despite invasion of adjacent regions of the “zombie fly” brain by E. muscae cells and extensive host tissue damage in the body cavity. The blood-brain barrier of flies late in their infection was significantly permeabilized, suggesting that factors in the hemolymph may have greater access to the central nervous system during summiting. Metabolomic analysis of hemolymph from summiting flies revealed differential abundance of several compounds compared to non-summiting flies. Transfusing the hemolymph of summiting flies into non-summiting recipients induced a burst of locomotion, demonstrating that factor(s) in the hemolymph likely cause summiting behavior. Altogether, our work reveals a neuro-mechanistic model for summiting wherein fungal cells perturb the fly’s hemolymph, activating a neurohormonal pathway linking clock neurons to juvenile hormone production in the CA, ultimately inducing locomotor activity in their host.

    1. Neuroscience
    Flavia Venetucci Gouveia, Jurgen Germann ... Clement Hamani
    Research Article Updated

    Deep brain stimulation targeting the posterior hypothalamus (pHyp-DBS) is being investigated as a treatment for refractory aggressive behavior, but its mechanisms of action remain elusive. We conducted an integrated imaging analysis of a large multi-centre dataset, incorporating volume of activated tissue modeling, probabilistic mapping, normative connectomics, and atlas-derived transcriptomics. Ninety-one percent of the patients responded positively to treatment, with a more striking improvement recorded in the pediatric population. Probabilistic mapping revealed an optimized surgical target within the posterior-inferior-lateral region of the posterior hypothalamic area. Normative connectomic analyses identified fiber tracts and functionally connected with brain areas associated with sensorimotor function, emotional regulation, and monoamine production. Functional connectivity between the target, periaqueductal gray and key limbic areas – together with patient age – were highly predictive of treatment outcome. Transcriptomic analysis showed that genes involved in mechanisms of aggressive behavior, neuronal communication, plasticity and neuroinflammation might underlie this functional network.